Anderson-fabry disease: role of traditional and new cardiac MRI techniques

Br J Radiol

12 Luglio Lug 2021 24 days ago
  • Pontone G

Anderson-Fabry (FD) disease is a rare X-linked disorder caused by different mutations in the Galactosidase α (GLA) gene, which leads to α-galactosidase A enzyme deficiency and the storage of glycosphingolipids in different kinds of organs, included the heart. This results in myocardial inflammation and left ventricular hypertrophy (LVH) and fibrosis. Echocardiography and cardiac magnetic resonance (C-MRI), in particular with new techniques, such as mapping analysis, late gadolinium enhancement (LGE) assessment and strain imaging, are important tools that allow a correct diagnosis, discriminating FD from other hypertrophic heart conditions. C-MRI is able to detect tissue alterations in the early stages of the disease, when an appropriate treatment could be more effective, and it has a fundamental role in monitoring therapy.

Reference

Anderson-fabry disease: role of traditional and new cardiac MRI techniques. Caredda G, Bassareo PP, Cherchi MV, Pontone G, Suri JS, Saba L. Br J Radiol. 2021 Jul 8:20210020. doi: 10.1259/bjr.20210020

Go to PubMed